We are live on
!
Find out more
BE
Bonness Enterprises Portfolio holdings
AUM
$310M
1-Year Est. Return
24.22%
This Fund
S&P 500
This Quarter
Est. Return
+0.42%
1 Year Est. Return
+24.22%
3 Year Est. Return
+94.56%
5 Year Est. Return
+137.52%
10 Year Est. Return
+441.57%
AUM
$273M
AUM Growth
-$3.96M
(-1.4%)
Cap. Flow
-$2.88M
Cap. Flow
% of AUM
-1.06%
Top 10 Holdings %
Top 10 Hldgs %
74.96%
Holding
38
New
–
Increased
3
Reduced
5
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$988K |
| 2 |
Cisco
CSCO
|
+$636K |
| 3 |
Intel
INTC
|
+$68.8K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Progressive
PGR
|
+$1.88M |
| 2 |
John Wiley & Sons Class A
WLY
|
+$1.85M |
| 3 |
Applied Materials
AMAT
|
+$744K |
| 4 |
GE Aerospace
GE
|
+$100K |
| 5 |
Stryker
SYK
|
+$10.2K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 44.96% |
| 2 | Healthcare | 24.08% |
| 3 | Technology | 21.58% |
| 4 | Consumer Staples | 3.21% |
| 5 | Industrials | 2.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Progressive
PGR
$122B
| $115M | 41.89% |
551,282
-8,975
| -2% | -$1.88M |
|
|
2
Stryker
SYK
$130B
| $22.3M | 8.17% |
65,664
-30
| -0% | -$10.2K |
|
3
Microsoft
MSFT
$3.63T
| $18.2M | 6.67% |
40,800
| – | – |
|
4
Apple
AAPL
$4.51T
| $11.5M | 4.2% |
54,440
| – | – |
|
5
Merck
MRK
$313B
| $8.6M | 3.15% |
69,500
| – | – |
|
|
6
Applied Materials
AMAT
$408B
| $6.33M | 2.32% |
26,836
-3,464
| -11% | -$744K |
|
7
AbbVie
ABBV
$434B
| $6.33M | 2.32% |
36,900
| – | – |
|
8
Thermo Fisher Scientific
TMO
$213B
| $6.05M | 2.21% |
10,935
| – | – |
|
9
Johnson & Johnson
JNJ
$609B
| $5.65M | 2.07% |
38,638
| – | – |
|
|
MRSH
10
Marsh
MRSH
$91.5B
| $5.37M | 1.97% |
25,500
| – | – |
|
11
IBM
IBM
$214B
| $5.11M | 1.87% |
29,564
| – | – |
|
12
Emerson Electric
EMR
$85.4B
| $4.74M | 1.73% |
43,000
| – | – |
|
|
13
Cisco
CSCO
$454B
| $4.57M | 1.67% |
96,100
+13,400
| +16% | +$636K |
|
14
Nucor
NUE
$58.9B
| $4.31M | 1.58% |
27,235
| – | – |
|
|
15
Pfizer
PFE
$142B
| $4.21M | 1.54% |
150,608
+35,900
| +31% | +$988K |
|
16
Unilever
UL
$137B
| $4.18M | 1.53% |
67,591
| – | – |
|
|
17
Intel
INTC
$456B
| $4.06M | 1.49% |
131,150
+2,100
| +2% | +$68.8K |
|
18
Abbott
ABT
$185B
| $3.4M | 1.24% |
32,700
| – | – |
|
19
Corning
GLW
$126B
| $3.35M | 1.23% |
86,300
| – | – |
|
20
Procter & Gamble
PG
$337B
| $2.7M | 0.99% |
16,400
| – | – |
|
21
Philips
PHG
$25.5B
| $2.62M | 0.96% |
112,227
-7
| -0% | -$157 |
|
22
Agilent Technologies
A
$39.2B
| $2.32M | 0.85% |
17,900
| – | – |
|
23
Bristol-Myers Squibb
BMY
$132B
| $2.26M | 0.83% |
54,300
| – | – |
|
24
United Parcel Service
UPS
$90.4B
| $2.05M | 0.75% |
14,950
| – | – |
|
25
GSK
GSK
$102B
| $2.04M | 0.75% |
52,960
| – | – |
|
Similar funds
IPW
TL
RGC
IR
TWM
PH
CCG
FI
Bonness Enterprises's Q2 2024 Portfolio in Review
As of Q2 2024, Bonness Enterprises held 38 positions worth $273M, down 1.4% from $277M the previous quarter. Its ten largest holdings account for 75% of the portfolio.
Trading was light in Q2 2024: portfolio turnover was 2.6%. Bonness Enterprises opened no new positions and exited 1, leaving the 38-position portfolio largely intact.
By sector, the portfolio is most concentrated in Financials at 45% of assets, up from 45% a quarter earlier, followed by Healthcare and Technology.
- Bonness Enterprises added most to Pfizer in Q2 2024, an estimated $988K increase.
- Bonness Enterprises's biggest Q2 2024 reduction was Progressive, cutting an estimated $1.88M.
- Bonness Enterprises fully exited John Wiley & Sons Class A in Q2 2024, selling an estimated $1.85M.
- Bonness Enterprises's ten largest holdings make up 75% of its $273M portfolio in Q2 2024.
- Bonness Enterprises opened 0 new positions and closed 1 in Q2 2024.
- Bonness Enterprises's portfolio value fell 1.4% quarter-over-quarter to $273M.
Based on Bonness Enterprises's 13F filing for Q2 2024, filed 25 Jul 2024.